tDCS for Cancer-Related Fatigue and Weakness

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 10, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

December 31, 2027

Conditions
Cancer-related FatigueNeuromodulation
Interventions
DEVICE

Active tDCS + elbow flexion exercise

"Participants will receive anodal tDCS targeting motor-related cortical areas using either traditional sponge-based or high-definition (HD)-tDCS configurations. The intervention is delivered at 1.5-2.0 mA for 20-30 minutes, either before or during a sustained submaximal isometric contraction task designed to induce fatigue.~tDCS will be administered in a counterbalanced crossover design, where each participant completes both active stimulation and sham stimulation conditions in separate sessions spaced at least one week apart. Sham stimulation mimics the sensory effects of active tDCS (30-second ramp-up and down) without delivering sustained current.~The intervention is unique as the target population is cancer survivors with persistent fatigue \>6 months post-treatment. Also, the tDCS is combined with neurophysiological assessments, including EMG, TMS, EEG, and MRI, to provide neurophysiological evidence of acute effects."

DRUG

Sham tDCS + elbow flexion exercise

"Participants will receive anodal tDCS targeting motor-related cortical areas using either traditional sponge-based or high-definition (HD)-tDCS configurations. The intervention is delivered at 1.5-2.0 mA for 30 seconds to mimic the sensation of active tDCS (20 minutes long), either before or during a sustained submaximal isometric contraction task designed to induce fatigue.~tDCS will be administered in a counterbalanced crossover design, where each participant completes both active stimulation and sham stimulation conditions in separate sessions spaced at least one week apart. Sham stimulation mimics the sensory effects of active tDCS (30-second ramp-up and down) without delivering sustained current."

Trial Locations (1)

07052

Kessler Foundation, West Orange

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Kessler Foundation

OTHER